Bayer, EDB to fund S$30m regional disease research
Effort will deepen cancer research and expand into heart and eye diseases
Singapore
PHARMACEUTICAL giant Bayer HealthCare and the Singapore Economic Development Board (EDB) will jointly foster translational and clinical research for diseases prevalent in Asia over the next five years, they announced at a launch ceremony on Wednesday.
EDB will facilitate collaborations between Bayer HealthCare and its partner institutes - including SingHealth Duke-NUS Academic Medical Centre and National University Health System (NUHS) - to increase existing research efforts in cancer treatment, and expand into the research of heart and eye diseases.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
International
Outgoing Singapore, Indonesia leaders to hold their final retreat in Bogor on Apr 29
Beijing city to subsidise domestic AI chips, targets self-reliance by 2027
China passes tariff law as tensions with trading partners simmer
Blinken meets Chinese counterpart Wang Yi in Beijing
South Korea’s public finances no longer a credit rating ‘strength’: Fitch
UK consumer confidence improves as inflation and taxes fall